iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange of up to 67 million shares under a proposed placement to raise no less than SG$5 million in gross proceeds, according to a Thursday filing with the Singapore Exchange.
Shares of the company were up nearly 2% in Friday trading.